Miles White, who reshaped Abbott Laboratories over the past decade through big deals, is positioned for another game-changer. Pharmaceutical companies are expected to go on buying sprees this year for potential blockbuster drugs at bargain prices. Abbott's buoyant stock price and record cash flow ...
Copyright CRAIN - Crain's
